|
Real-time Estimate
Cboe Europe
08:28:35 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 126.31 CHF | -0.15% |
|
+3.02% | +15.29% |
| 07:14am | How cheap Chinese antibiotics threaten Europe's last major penicillin plant | RE |
| 05:51am | BofA: UCB's Bimzelx Sets 'Very High' Bar Ahead of Q4 Competitor Data in Hidradenitis Suppurativa | MT |
| Market Cap | 291B 259B 240B 218B 409B 27,611B 416B 2,885B 1,133B 14,449B 1,093B 1,071B 46,096B | P/E 2026 * |
21.5x | P/E 2027 * | 18x |
|---|---|---|---|---|---|
| Enterprise Value | 323B 288B 267B 242B 454B 30,609B 462B 3,198B 1,256B 16,018B 1,212B 1,187B 51,100B | EV / Sales 2026 * |
5.61x | EV / Sales 2027 * | 5.22x |
| Free-Float |
91.66% | Yield 2026 * |
2.85% | Yield 2027 * | 2.97% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
London S.E.
| 0QLR | Delayed | |
|
CBOE
| 0QLR | Real-time | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Xetra
| NOT | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
Xetra
| NOT | Delayed | |
|
OTC Markets
| NVSEF | Delayed | |
|
Börse Stuttgart
| NOT | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | -0.15% | ||
| 1 week | +3.02% | ||
| Current month | +5.34% | ||
| 1 month | +8.80% | ||
| 3 months | +0.65% | ||
| 6 months | +8.84% | ||
| Current year | +15.29% |
| 1 week | 123.3 |  | 127 |
| 1 month | 114.86 | | 127 |
| Current year | 107.68 | | 132.68 |
| 1 year | 97.05 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Karen Hale
CMP | Compliance Officer | 58 | 2025-04-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Sell | -5,200 | 0.0003% | |||
| 5/4/26 | Sell | 6,800 | 0.0003% | |||
| 2/17/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | +3.02% | +20.85% | +49.54% | 291B | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,144B | |
| +2.19% | +4.32% | +33.88% | +69.52% | 625B | |
| +2.26% | +5.37% | +24.57% | +97.69% | 511B | |
| -0.17% | +4.96% | +38.64% | +63.88% | 377B | |
| +3.25% | +4.45% | +71.80% | +44.44% | 366B | |
| +0.05% | +2.59% | +1.15% | +24.93% | 262B | |
| +3.29% | +6.32% | +44.71% | +57.43% | 237B | |
| +2.25% | +5.81% | +27.13% | +101.17% | 194B | |
| -0.37% | +1.52% | -26.79% | -61.91% | 174B | |
| Average | -0.34% | +5.86% | +29.46% | +56.63% | 418.16B | |
| Weighted average by Cap. | -0.45% | +6.70% | +38.10% | +75.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.64B 51.31B 47.55B 43.09B 80.98B 5,461B 82.34B 571B 224B 2,858B 216B 212B 9,117B | 61.32B 54.58B 50.58B 45.84B 86.14B 5,809B 87.58B 607B 238B 3,040B 230B 225B 9,697B |
| Net income | 14.34B 12.76B 11.83B 10.72B 20.14B 1,358B 20.48B 142B 55.75B 711B 53.78B 52.66B 2,267B | 15.94B 14.19B 13.15B 11.91B 22.39B 1,510B 22.76B 158B 61.97B 790B 59.78B 58.54B 2,521B |
| Net Debt | 31.64B 28.16B 26.1B 23.65B 44.45B 2,998B 45.2B 313B 123B 1,569B 119B 116B 5,004B | 28.7B 25.55B 23.68B 21.45B 40.32B 2,719B 40.99B 284B 112B 1,423B 108B 105B 4,539B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | CHF 126.36 | -0.11% | 1,177,555 |
| 26-10-20 | CHF 126.50 | +1.85% | 3,198,959 |
| 26-10-19 | CHF 124.20 | -0.40% | 2,837,515 |
| 26-10-16 | CHF 124.70 | -0.95% | 4,531,183 |
| 26-10-15 | CHF 125.90 | +2.64% | 4,727,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
